Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer
about
Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphomaSmall-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgeryRisk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclinesOptimal approach in early breast cancer: Radiation therapyWhole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer.Reducing cardiac doses: a novel multi-leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left-sided breast cancer.Tangential Field Radiotherapy for Breast Cancer-The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?Biological dosimetry for breast cancer radiotherapy: a comparison of external beam and intraoperative radiotherapy.Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer.Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast-conserving surgery and radiation therapy: a reviewCardiac counterclockwise rotation is a risk factor for high-dose irradiation to the left anterior descending coronary artery in patients with left-sided breast cancer who receiving adjuvant radiotherapy after breast-conserving surgery.Imaging dose in breast radiotherapy: does breast size affect the dose to the organs at risk and the risk of secondary cancer to the contralateral breast?Risk of valvular heart disease after treatment for Hodgkin lymphomaAssessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study.Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy.Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and TrastuzumabComparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiationInfluence of different boost techniques on radiation dose to the left anterior descending coronary arteryTreatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH).Predicting radiation-induced valvular heart damage.Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Uncertainties in estimating heart doses from 2D-tangential breast cancer radiotherapy.Prone breast forward intensity-modulated radiotherapy for Asian women with early left breast cancer: factors for cardiac sparing and clinical outcomes.External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparisonDEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.Is there a dose-response relationship for heart disease with low-dose radiation therapy?The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiationRadiation dose to the left anterior descending coronary artery during interstitial pulsed-dose-rate brachytherapy used as a boost in breast cancer patients undergoing organ-sparing treatment.A cardiac contouring atlas for radiotherapyDelineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.Effect of accurate heart delineation on cardiac dose during the CONVERT trial.Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries.The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.
P2860
Q30486369-A34F52DB-887B-49A4-B269-3EF0B4A1404AQ33579820-E141FB75-A62A-47E2-B4EF-618FC332EF25Q33590549-CA2AFA54-39A8-4501-9E5D-AEDEDD45A225Q33640172-DB59B1C4-DEC5-4A23-9BC0-1CB0DE84743FQ33699050-4C8423D0-D4D3-4640-A943-81D11F1A2414Q33733680-F37F2A34-AF51-4DA3-B330-9CC707D736CAQ33753740-C060FDFC-D172-43CA-ACB2-A2DA89626AA0Q33809914-3F1A39C7-93FA-4AF5-9506-7FE65B0FF3DEQ33887892-92CD39CD-C920-4669-81C9-3E46C32910C5Q33923050-45F2FA32-7D6C-43A8-A0BE-9920422080B2Q34435278-F83B5949-E540-497F-ADB3-017BDF541AEDQ34510494-0A65245A-8B3B-4230-BF5B-D58631118202Q35135021-6ACC665F-0B70-419D-9B79-AB27653B7F79Q35192030-E5FD3E4B-0678-427F-919C-5CB2FAF85DFCQ35386920-53BF1CBB-5B56-402A-8DD0-AA04D40167FAQ35530285-D62241F3-2F80-468E-B651-EEA080A12409Q35591822-6338E082-5E06-407E-994D-1B3AAD910805Q35834621-C06E8AEB-04CE-4917-9B46-78E963D97760Q36064820-FC9F0408-F2AA-4B09-8BAA-4B92CB19A3B5Q36078263-D5CD8186-135E-4ACC-9915-F4DD0B2F6345Q36083037-D617FAA2-A2FC-4D7F-8BDA-97B608EE218EQ36166891-3BFFEA18-F033-4C6A-B978-C8BAE11C9FB8Q36175391-E9D7098A-E888-41B9-901C-C7A3865F418BQ36672745-02E73DEF-42F2-4F39-AD12-2D6FC3B1C064Q36729600-4219FB32-5970-44D1-AD56-4349A6EA345FQ36793640-452F9E0C-04E9-4E6D-A00D-874449CFD64CQ36808805-172B5AAC-1570-4D16-B96E-8EF5CE1BC7D6Q36914117-2708CB10-AB71-40F1-87A5-86AA7603559BQ37154072-9FD0C838-6E98-477E-958E-956055F95B6EQ37246919-495B0F6C-66D7-4CBF-BDAD-7A4F5C1CABEBQ37301839-097ABEA2-F4AF-48B5-B051-789B718A8AAEQ37523402-EB400B8B-9D8B-457B-B8E3-2786C19D8E01Q37549514-9E72FE45-A681-4798-821E-2B01DC4B2E54Q37694569-744FC8FE-219C-4384-855A-64B978B14900Q37708633-CFDC812A-7E1F-41CB-9842-E1D5C830C4DAQ38082844-F851675B-449F-47D9-9DD3-6A6CF9E4542EQ38378765-945F2A81-5A66-40DD-8E52-D6DEAD1A99A4Q38611361-95B0A23B-3179-45F6-8E1C-C586D6530FD6Q38620687-B6AA9DCC-09EE-4B7D-A88E-39F0744D3465Q38663192-1921067C-91AB-4CC8-8B2F-9C6498FB5569
P2860
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development and validation of ...... ng treatment for breast cancer
@ast
Development and validation of ...... ng treatment for breast cancer
@en
Development and validation of ...... ng treatment for breast cancer
@nl
type
label
Development and validation of ...... ng treatment for breast cancer
@ast
Development and validation of ...... ng treatment for breast cancer
@en
Development and validation of ...... ng treatment for breast cancer
@nl
prefLabel
Development and validation of ...... ng treatment for breast cancer
@ast
Development and validation of ...... ng treatment for breast cancer
@en
Development and validation of ...... ng treatment for breast cancer
@nl
P2093
P2860
P1476
Development and validation of ...... ng treatment for breast cancer
@en
P2093
Aamer Chughtai
James A Hayman
Janice Larouere
Jean M Moran
Julie Soriano
June L Chan
Laura Freedman
Lori J Pierce
Robin Marsh
P2860
P356
10.1016/J.IJROBP.2009.10.058
P407
P50
P577
2010-04-24T00:00:00Z